Sources sought, total small business set-aside
Sources Sought Notice FDA Office of Clinical Pharmacology (OCP)/Division of Applied Regulatory Science (DARS) Purchase of Phenomenex High-Pressure Liquid Chromatography (HPLC) Core-Shell Technology Columns and Consumables
CDER-OTS-25-C-1691
Food and Drug Administration, FDA Office of Acq Grant SVCS. Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology).
Response deadline
July 1, 2025 at 5:00 AM EDT
Closed 488 days ago. Posted June 24, 2025. Scheduled to archive July 16, 2025.
Get the next one like this from Food and Drug Administration by email, the day it is posted.Find my opportunities
This one closed in 2025
127 like it are open now in research and development in the physical, engineering, and life sciences (except nanotechnology and biotechnology)
- Risk Underlying Rural Areas Longitudinal (RURAL) H
National Institutes of Health, National Institutes of Health Olao
SolicitationNAICS 541715Bethesda, MD75N98026R00074Closes in 4 daysNov 5 - Prototype development for Battlefield Wound Infection Prevention and Treatment (BWI P&T) Barrier Combination
Defense Health Agency (Dha), Defense Health Agency
SolicitationNAICS 541715Frederick, MDHT9427-26-R-E020Closes in 5 daysNov 6 - Hubble Space Telescope (HST) Servicing
National Aeronautics and Space Administration, NASA Goddard Space Flight Center
Sources soughtNAICS 541715Greenbelt, MD80GSFC27RFIHSTSCloses in 29 daysNov 30
Description
As published on SAM.gov.
The Food and Drug Administration (FDA) is seeking to purchase critical supplies neccesary for the Division of Applied Regulatory Science (DARS) bioanalytical lab to continue supporting mission- critical research focused on review questions, translational science, and emerging public health issues for the Center for Drug Evaluation and Research (CDER) and FDA.
DARS operates six total labs that focus on developing and evaluating novel tools, standards, and approaches that increase the regulatory efficiency of developing and reviewing safe and effective CDER products. These operational supplies are essential for the continuance of these projects across all lab groups, and for continued preparedness to be able to respond to emergent public health issues when called upon. We kindly request that each interested vendor also complete and submit the attached vendor feedback form along with a capability statement for consideration.
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
June 24, 2025
Sources sought
Due July 1, 2025 at 5:00 AM EDT. SAM.gov, notice 5e9d911b92e047ec859af4b5aa3d66f0
Points of contact
- Brandon Rafusbrandon.rafus@fda.hhs.gov